Maxim Group Downgrades Mateon Therapeutics (MATN) to Hold
Tweet Send to a Friend
Maxim Group downgraded Mateon Therapeutics (OTC: MATN) from Buy to Hold.The downgrades follows an S-1 statement seeking to raise $8.0M ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
